Neuberger Berman Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,500
Closed -$350K 1659
2018
Q4
$350K Sell
2,500
-5,000
-67% -$759K ﹤0.01% 1333
2018
Q3
$1.28M Buy
7,500
+5,000
+200% +$840K ﹤0.01% 1138
2018
Q2
$434K Buy
+2,500
New +$376K ﹤0.01% 1422
2017
Q4
Sell
-4,500
Closed -$415K 1852
2017
Q3
$415K Sell
4,500
-10,500
-70% -$816K ﹤0.01% 1343
2017
Q2
$1.2M Buy
+15,000
New +$831K ﹤0.01% 1115

Other funds holding LOXO

Neuberger Berman Group's LOXO Position: Q1 2019 in Review

Neuberger Berman Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,500 shares — an estimated $350K sold.

Neuberger Berman Group first reported a position in LOXO in Q2 2017 and held it in 5 quarters. The position peaked at $1.28M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Neuberger Berman Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Neuberger Berman Group sold 2,500 Loxo Oncology, Inc shares in Q1 2019, an estimated $350K.
  • Neuberger Berman Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 5 quarters.
  • Neuberger Berman Group's Loxo Oncology, Inc position peaked at $1.28M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Neuberger Berman Group's 13F filing for Q1 2019, filed 13 May 2019.